Disturbance of lymph circulation induced chronic renal failure and renal fibrosis, which were aggravated by lymphatic vessels ligation combined with contralateral nephrectomy. The effect of lymphatic ducts ligation on renal lesions may be explained by enhanced activation of the TGF-beta1/Smad signalling.
Klebsiella pneumoniae is an important cause of healthcare-associated
infections worldwide. Selective pressure, the extensive use of antibiotics, and the
conjugational transmission of antibiotic resistance genes across bacterial species
and genera facilitate the emergence of multidrug-resistant (MDR) K.
pneumoniae. Here, we examined the occurrence, phenotypes and genetic
features of MDR K. pneumoniae isolated from patients in intensive
care units (ICUs) at the First Affiliated Hospital of Xiamen University in Xiamen,
China, from January to December 2011. Thirty-eight MDR K. pneumoniae
strains were collected. These MDR K. pneumoniae isolates possessed
at least seven antibiotic resistance determinants, which contribute to the high-level
resistance of these bacteria to aminoglycosides, macrolides, quinolones and
β-lactams. Among these isolates, 24 strains were extended-spectrum β-lactamase (ESBL)
producers, 2 strains were AmpC producers, and 12 strains were both ESBL and AmpC
producers. The 38 MDR isolates also contained class I (28/38) and class II integrons
(10/38). All 28 class I-positive isolates contained aacC1,
aacC4, orfX, orfX’ and aadA1
genes. β-lactam resistance was conferred through bla
SHV (22/38), bla
TEM (10/38), and bla
CTX-M (7/38). The highly conserved bla
KPC-2 (37/38) and bla
OXA-23(1/38) alleles were responsible for carbapenem resistance, and a
gyrAsite mutation (27/38) and the plasmid-mediated
qnrB gene (13/38) were responsible for quinolone resistance.
Repetitive-sequence-based PCR (REP-PCR) fingerprinting of these MDR strains revealed
the presence of five groups and sixteen patterns. The MDR strains from unrelated
groups showed different drug resistance patterns; however, some homologous strains
also showed different drug resistance profiles. Therefore, REP-PCR-based analyses can
provide information to evaluate the epidemic status of nosocomial infection caused by
MDR K. pneumoniae; however, this test lacks the power to
discriminate some isolates. Thus, we propose that both genotyping and REP-PCR typing
should be used to distinguish genetic groups beyond the species level.
Urinary orosomucoid is a DN-related biomarker, which is associated with the development and progression of DN. Furthermore, increased UOER is an independent risk factor of DN.
Whole blood and serum samples of Chinese stable chronic renal failure (CRF) patients (n = 81), hemodialysis patients (n = 135), posttransplant patients (n = 60), and subjects with normal renal function (NRF; N = 42) were collected, as well as water and dialysate samples from five dialysis centers. The concentration of selenium (Se), lead (Pb), and cadmium (Cd) was measured by atomic absorption spectrometry. The mean serum Se levels in patients with different degrees of renal failure were significantly lower than those of subjects with NRF (p < 0.01). Pb levels were not increased in renal failure patients, while the Cd levels in patients with various degrees of renal failure were higher than in subjects with NRF (p < 0.05). After correcting the results of Pb and Cd for hematocrit (Hct) however, Pb levels of dialysis patients were also increased. In the dialysis population under study, blood Pb and Cd levels were closely related to the time on dialysis, while contamination of the final dialysate may also contribute to the increased blood Cd and to a less extent Pb levels. Correction for Hct may be recommended to accurately compare blood Pb and Cd levels in dialysis patients and CRF patients with varying degrees of anemia to those of subjects with NRF.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by aberrant T cell immune response. Diffuse proliferative lupus nephritis (LN-IV) is the most common, severe, and active form of lupus nephritis. In this study, we investigated the production of Th1, Th2, and Th17 cytokines in prediction of active form of LN-IV. ProcartaPlex multiplex immunoassays panels were used for detection of serum Th1, Th2, and Th17 cytokines profiling. Th1 and Th17 cytokines (IL-18, IFN-γ, IL-12p70, IL-6, and IL-17A) were considerably expressed in the serum of lupus nephritis IV patients in comparison to the healthy control. However, only IL18 and IL6 were higher in class IV versus class III lupus nephritis. Importantly, the ratios of Th1/Th2 (IL-18/IL-4) and Th17/Th2 (IL-17A/IL-4) were significantly elevated in LN-IV when compared with LN-III, LN-V, and healthy controls. Consistently, the serum cytokines IL-18, IL-17A, and IFN-γ were markedly expressed in LN-IV patient glomeruli and interstitial tissue compared to other classes of LN by IHC. ROC further suggests that IL-18 was a potential marker for LN-IV. The data from our study suggests that the early detection and quantification of these cytokines may help in prediction of active form of LN-IV.
Erythropoietin (EPO) exerts (renal) tissue protective effects. Since it is unclear whether this is a direct effect of EPO on the kidney or not, we investigated whether EPO is able to protect human renal tubular epithelial cells (hTECs) from oxidative stress and if so which pathways are involved. EPO (epoetin delta) could protect hTECs against oxidative stress by a dose-dependent inhibition of reactive oxygen species formation. This protective effect is possibly related to the membranous expression of the EPO receptor (EPOR) since our data point to the membranous EPOR expression as a prerequisite for this protective effect. Oxidative stress reduction went along with the upregulation of renoprotective genes. Whilst three of these, heme oxygenase-1 (HO-1), aquaporin-1 (AQP-1), and B-cell CLL/lymphoma 2 (Bcl-2) have already been associated with EPO-induced renoprotection, this study for the first time suggests carboxypeptidase M (CPM), dipeptidyl peptidase IV (DPPIV), and cytoglobin (Cygb) to play a role in this process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.